The results showed that the SGs could inhibit the proliferation of Cholangiocarcinoma Cells (CCA), and its mechanism of inhibition was mediated by inhibited EGFR activation and the EGFR/ERK signaling pathway. The gene discussed is EGFR; the disease is cholangiocarcinoma.